|
|
|
|
|
|
JiangSu HengTuo Pharmaceuticals Co., Ltd is a chemistry based company specializing in the design and custom synthesis of organic compounds, research of new drugs, and the development of new chemical production technologies.
We have established two own laboratories with strong R & D capability in organic synthesis. laboratories located in ShangHai and Nanjing, covering an area over 600 sqm, equipped with a complete set of technical analytical equipments and instruments. Our research center is devoted to new product development and scale-up. Our core business consists of process development, custom synthesis, contract research services, lead development, and a product line that includes rare fine chemicals. We have small scale pilot laboratory, scale-up pilot workshops and a team of experienced researchers and engineers. We can complete the reaction conditions: 0.5MPa - 25MPa, -75℃ - 400℃。Jiangsu HengTuo was established in2010.After several years of involvements in this field, we have accumulated a wealth of experience in the lab development, scaling up, and final production process design. We offer products ranging from gram to ton scale for pharmaceutical, drug discovery, and biotechnology industries. according to customers requirements.
Prasugrel related substance, Moexipril related substance, Minodronic acid related substance, Dronedarone related substance, some API are under test, such as Romiplostim related substance, Azintamide intermediate and other more intermediate of MK5478 are the leading products of JiangsuHengTuo. And it also undertakes the Custom Synthesis services as R&D, pilot-scale and commercial production of all kinds of fine chemicals, and the quantity size is from mg to tons. We always provide competitive price and perfect quality with good services for kinds of contract manufacturing requirement of our clients. |
|
|
| Vandetanib, (1-(tert-butoxycarbonyl)piperidin-4-yl)methyl methanesulfonate, methyl 4-((piperidin-4-yl)methoxy)-3-methoxybenzoate, methyl 4-((1-methylpiperidin-4-yl)methoxy)-3-methoxybenzoate, methyl 4-((1-methylpiperidin-4-yl)methoxy)-5-methoxy-2-nitrobenzoate, methyl 4-((1-methylpiperidin-4-yl)methoxy)-2-amino-5-methoxybenzoate, 6-methoxy-7-(1-methylpiperidin-4-yl)quinazolin-4(3H)-one, 4-chloro-6-methoxy-7-(1-methylpiperidin-4-yl)quinazoline, Apixaban, (3-Chloro-5,6-dihydro-1-(4-nitrophenyl)-2(1H)-pyridinone ), (ethyl 6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate ), (4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester ), Tofacitinib citrate, 3-Amino-4-methylpyridine, 1-benzyl-3-((methoxycarbonyl)amino)-4-methylpyridin-1-ium bromide, (1-Benzyl-4-methyl-1,2,5,6-tetrahydropyridin-3-yl)carbamic acid methyl ester, methyl (4-methylpiperidin-3-yl)carbamate, methyl (1-benzyl-4-methylpiperidin-3-yl)carbamate, 1-benzyl-N,4-dimethylpiperidin-3-amine, 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine |
|
|
| Company : |
JiangSu HengTuo Pharmaceuticals Co., Ltd |
| Email: |
Contact us |
| URL: |
********
|
| Phone: |
*********
|
| Fax : |
*********
|
| Country : |
China |
| Address : |
*********
|
|
|
|
|
|
